USANA Health Sciences (NYSE:USNA) Shares Gap Up Following Earnings Beat

Shares of USANA Health Sciences, Inc. (NYSE:USNA) gapped up before the market opened on Wednesday following a stronger than expected earnings report. The stock had previously closed at $31.96, but opened at $35.67. USANA Health Sciences shares last traded at $32.93, with a volume of 84,067 shares.

The company reported $0.64 earnings per share for the quarter, topping the consensus estimate of $0.49 by $0.15. USANA Health Sciences had a return on equity of 10.64% and a net margin of 6.30%. The firm had revenue of $213.61 million during the quarter, compared to analyst estimates of $208.82 million.

Analysts Set New Price Targets

A number of research analysts recently issued reports on the stock. Sidoti lowered shares of USANA Health Sciences from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, February 18th. StockNews.com downgraded USANA Health Sciences from a “strong-buy” rating to a “buy” rating in a research report on Friday, February 14th. Finally, DA Davidson boosted their price objective on USANA Health Sciences from $35.00 to $38.00 and gave the stock a “neutral” rating in a research report on Thursday, January 2nd.

Institutional Investors Weigh In On USANA Health Sciences

Several hedge funds have recently modified their holdings of USNA. R Squared Ltd bought a new position in USANA Health Sciences during the fourth quarter worth $28,000. Safe Harbor Fiduciary LLC acquired a new stake in USANA Health Sciences in the 3rd quarter worth $30,000. KBC Group NV increased its holdings in shares of USANA Health Sciences by 96.6% during the 3rd quarter. KBC Group NV now owns 1,056 shares of the company’s stock worth $40,000 after purchasing an additional 519 shares during the period. KLP Kapitalforvaltning AS acquired a new position in shares of USANA Health Sciences during the fourth quarter valued at about $83,000. Finally, Quantbot Technologies LP acquired a new position in shares of USANA Health Sciences during the fourth quarter valued at about $132,000. 54.25% of the stock is owned by institutional investors.

USANA Health Sciences Price Performance

The firm has a market cap of $632.26 million, a P/E ratio of 11.72, a PEG ratio of 0.93 and a beta of 0.87. The company’s 50 day moving average is $33.62 and its two-hundred day moving average is $36.61.

USANA Health Sciences Company Profile

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.